RLMD
Relmada Therapeutics, Inc.Company with tickers: RLMD
CIK
1553643
CUSIP
75955J402
Shares Outstanding
104,890,223
13F Activity (30d)
98 filings
98 filers
Price
$7.14
Market Cap
$738.43M
P/E Ratio
-4.92
EPS (Diluted)
$-1.45
52W High
$8.00
52W Low
$0.49
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Type | Date | Period | Action |
|---|---|---|---|
| Earnings Call Transcript | 2026-03-31 | View | |
| Earnings Call Transcript | 2025-12-31 | View | |
| Earnings Call Transcript | 2025-09-30 | View | |
| Earnings Call Transcript | 2025-06-30 | View | |
| Earnings Call Transcript | 2025-03-31 | View | |
| Earnings Call Transcript | 2024-09-30 | View | |
| Earnings Call Transcript | 2024-06-30 | View | |
| Earnings Call Transcript | 2024-03-31 | View | |
| Earnings Call Transcript | 2023-12-31 | View | |
| Earnings Call Transcript | 2023-09-30 | View | |
| Earnings Call Transcript | 2023-06-30 | View | |
| Earnings Call Transcript | 2023-03-31 | View | |
| Earnings Call Transcript | 2022-12-31 | View | |
| Earnings Call Transcript | 2022-09-30 | View | |
| Earnings Call Transcript | 2022-06-30 | View | |
| Earnings Call Transcript | 2022-03-31 | View | |
| Earnings Call Transcript | 2021-12-31 | View | |
| Earnings Call Transcript | 2021-09-30 | View | |
| Earnings Call Transcript | 2021-06-30 | View | |
| Earnings Call Transcript | 2021-03-31 | View | |
| Earnings Call Transcript | 2020-12-31 | View |